Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

Rezultati

Title:	Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Authors :	Steg, Philippe Gabriel; ...; Dilić, Mirza; ...; Ristić, Arsen D. ; ...; Miličić, Davor; ...; Simić, Dragan V. ; Ivanović, Nikola; Davidović, Goran T. ; Tasić, Nebojša M.; Ašanin, Milika R. ; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Aranđelović, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1581);
Issue Date:	2019
Publication:	CIRCULATION
ISSN:	0009-7322 e1524-4539 Circulation Search Idenfier
Publisher:	Lippincott Williams & Wilkins, Hagerstown
Type:	Article
Collation:	vol. 140 br. 2 str. 103-112
DOI:	10.1161/CIRCULATIONAHA.118.038840
WoS-ID:	000476768100007
Scopus-ID:	2-s2.0-85068168207
PMID:	31117810
PMCID:	PMC6661243
URI:	https://enauka.gov.rs/handle/123456789/814089
URL:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661243/pdf/cir-140-103.pdf
Project:	Sanofi Regeneron Pharmaceuticals, Inc.
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	21a+M21a+

134
SCOPUS^TM

46
PubMed Central^TM

83
OpenCitations

122
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.